Centocor's Simponi May Cause Fatal Infections: FDA

Law360, New York (May 29, 2009, 12:00 AM EDT) -- Centocor Ortho Biotech Inc.'s new rheumatoid arthritis drug Simponi can cause severe and potentially fatal fungal infections, according to the U.S. Food and Drug Administration, marking the latest medication in a class of drugs known as tumor necrosis factor alpha blockers to come under scrutiny in recent months.

The FDA posted the warning on its Web site Wednesday along with a "Dear Healthcare Professional" letter that has been issued by Horsham, Pa.-based Centocor in order to warn doctors of the risk of serious fungal infections associated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.